The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDirect Line Regulatory News (DLG)

Share Price Information for Direct Line (DLG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 198.60
Bid: 198.80
Ask: 198.90
Change: 2.60 (1.33%)
Spread: 0.10 (0.05%)
Open: 197.70
High: 200.00
Low: 196.00
Prev. Close: 196.00
DLG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Ageas SA/NV

14 Mar 2024 08:52

RNS Number : 8601G
Fosun International Limited
14 March 2024

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

1. KEY INFORMATION

(a) Full name of discloser:

Fosun International Limited

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

Guo Guangchang, as majority shareholder of Fosun International Limited and its subsidiary, Fidelidade - Companhia de Seguros, S.A.?

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Ageas SA/NV

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

N/A

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

14 March 2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

Ordinary (ISIN: BE0974264930)

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

13,507,486*

7.19

(2) Cash-settled derivatives:

5,607,743**

2.98

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

3,452,524***

1.84

TOTAL:

19,115,229

10.17

3,452,524

1.84

* 3,452,524 of these shares are the subject of a variable pre-paid forward, which is capable of being cash settled or physically settled, at the election of Fosun International Limited.

** These instruments are also capable of being physically settled, at the election of Fosun International Limited.

*** These shares are the subject of a variable pre-paid forward, which acts as a hedge against a long holding of 3,452,524 shares.

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors' and other employee options)

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

Number of securities

Price per unit

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

Yes

Date of disclosure:

14 March 2024

Contact name:

Calvin Wong

Telephone number*:

+852-25093228

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

The Code can be viewed on the Panel's website at http://www.thetakeoverpanel.org.uk.

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the "Code")

1. KEY INFORMATION

Full name of person making disclosure:

Fosun International Limited

Name of offeror/offeree in relation to whose relevant securities the disclosure relates:

Ageas SA/NV

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class of relevant security

Product description

Long or short position

Number of securities to which derivative relates

Price per unit

Maturity date

3. AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:

Fosun International Limited has entered into an OTC variable prepaid forward with an investment banking counterparty, in respect of its holding of 3,452,524 ordinary shares in Ageas. This was entered into on 15 September 2023 at an initial price per share of EUR39.3649. It settles in tranches on consecutive business days from and including 5 August 2024 to and including 13 September 2024, either physically or in cash, at Fosun's election. The forward settlement price is floored at EUR35.4284 and capped at EUR47.2379 to provide Fosun with a hedge against downward price movements in return for a cap on sale proceeds. If physically settled, Fosun will deliver a variable amount of shares to the counterparty, based on the relationship between the share price at settlement and the cap and the floor. During the life of the forward, Fosun's 3,452,524 Ageas shares that are subject to this forward are secured in favour of the counterparty, with voting and income rights remaining with Fosun.

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RETUSSWRSWUOARR
Date   Source Headline
9th May 20245:15 pmRNSHolding(s) in Company
8th May 20242:00 pmRNSResult of AGM
8th May 20247:00 amRNSTrading Update for Q1 2024
2nd May 202411:30 amRNSSignificant Leadership Change
30th Apr 20242:15 pmRNSDirector/PDMR Shareholding
26th Apr 202412:00 pmRNSHolding(s) in Company
10th Apr 20247:00 amRNSDirect Line Group to appoint new CFO
9th Apr 20245:00 pmRNSDirector/PDMR Shareholding
9th Apr 20244:00 pmRNSHolding(s) in Company
8th Apr 20246:00 pmRNSDirector/PDMR Shareholding
8th Apr 20242:00 pmRNS2023 Solvency and Financial Condition Report
8th Apr 202412:00 pmRNSNotice of 2024 AGM
3rd Apr 202412:00 pmRNSDirector/PDMR Shareholding
2nd Apr 20242:11 pmRNSForm 8.5 (EPT/RI)- Replacement of Direct Line
28th Mar 20246:15 pmRNSDirector/PDMR Shareholding
28th Mar 20246:00 pmRNSDirector/PDMR Shareholding
28th Mar 20248:15 amRNSAnnual Financial Report
27th Mar 20241:28 pmRNSForm 8.3 - Direct Line Insurance Group plc
26th Mar 20243:20 pmRNSForm 8.3 - Direct Line Insurance Group Plc
26th Mar 20242:06 pmRNSForm 8.3 - Direct Line Insurance Group plc
26th Mar 20241:49 pmRNSForm 8.3 - Direct Line Insurance Group PLC
26th Mar 20241:47 pmRNSForm 8.5 (EPT/RI)- Replacement of Direct Line
26th Mar 20241:43 pmRNSForm 8.3 - Direct Line Insurance Group plc
26th Mar 202411:23 amRNSForm 8.5 (EPT/NON-RI)-Direct Line Insurance Group
26th Mar 202411:14 amRNSForm 8.5 (EPT/RI)-DIRECT LINE INSURANCE GROUP PLC
26th Mar 202411:13 amRNSForm 8.5 (EPT/RI)-Direct Line Insurance Group plc
26th Mar 20247:29 amRNSForm 8.3 - Direct Line Insurance Group plc
25th Mar 20245:06 pmRNSDIRECT LINE _8.5 EPT NON-RI_UK_BOFASE_Replacement
25th Mar 20243:21 pmRNSForm 8.3 - Ageas SA/NV
25th Mar 20243:20 pmRNSForm 8.3 - Direct Line Insurance Group Plc
25th Mar 20243:12 pmRNSForm 8.5(EPT/RI)-Direct Line Insurance Group Amend
25th Mar 20243:06 pmRNSForm 8.3 - Direct Line Insurance Group plc
25th Mar 20243:00 pmRNSForm 8.3 - Ageas SA/NV
25th Mar 20243:00 pmRNSForm 8.3 - Direct Line Insurance Group PLC
25th Mar 20242:26 pmEQSForm 8.3 - The Vanguard Group, Inc.: Direct Line Insurance Group plc
25th Mar 20242:20 pmRNSForm 8.3 - Direct Line Insurance Group plc
25th Mar 20242:17 pmRNSForm 8.3 -Direct Line Insurance Group plc
25th Mar 20242:08 pmRNSForm 8.3 - Ageas SA NV
25th Mar 20241:55 pmRNSForm 8.3 - Direct Line Insurance Group PLC
25th Mar 20241:26 pmRNSForm 8.3 - Direct Line Insurance Group plc
25th Mar 20241:10 pmRNSForm 8.5 (EPT/RI)- Replacement of Direct Line
25th Mar 202412:17 pmRNSForm 8.3 - Direct Line Insurance Group plc
25th Mar 202411:37 amRNSForm 8.5 (EPT/NON-RI)-Direct Line Insurance Group
25th Mar 202411:29 amRNSForm 8.5 (EPT/RI)-Direct Line Insurance Group plc
25th Mar 202411:29 amRNSForm 8.5 (EPT/RI)-DIRECT LINE INSURANCE GROUP PLC
25th Mar 202410:30 amRNSDIRECT LINE INSURANCE_8.5 EPT RI_UK_MLI
25th Mar 202410:29 amRNSDIRECT LINE INSURANCE_8.5 EPT NON-RI_UK_BOFASE
25th Mar 20249:18 amRNSForm 8.3 - Direct Line Insurance Group plc
25th Mar 20249:10 amRNSForm 8.5 (EPT/RI)- Direct Line Insurance Group plc
22nd Mar 20246:28 pmRNSResponse to Rule 2.8 termination announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.